Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
出版年份 2011 全文链接
标题
Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 18, Issue 4, Pages C19-C24
出版商
Bioscientifica
发表日期
2011-05-26
DOI
10.1530/erc-11-0112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Abstract 76: Mitochondrial filamentation
- (2011) Mario Gosalvez CANCER RESEARCH
- Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase
- (2011) Sabine Paternot et al. CELL CYCLE
- A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen
- (2011) Sophie Lehn et al. CELL CYCLE
- Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
- (2011) C. Thangavel et al. ENDOCRINE-RELATED CANCER
- Transcriptional activation of the senescence regulator Lsh by E2F1
- (2011) Jing Niu et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Cell cyclins: triggering elements of cancer or not?
- (2011) Michael Stamatakos et al. World Journal of Surgical Oncology
- Regulation of cyclin D1 gene expression: Figure 1
- (2010) Ini-Isabée Witzel et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Examination of the expanding pathways for the regulation of p21 expression and activity
- (2010) Yong-Sam Jung et al. CELLULAR SIGNALLING
- Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors
- (2010) Neil Johnson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression
- (2010) Mathieu Dalvai et al. PLoS One
- Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
- (2009) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
- (2009) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma membrane estrogen receptors
- (2009) Ellis R. Levin TRENDS IN ENDOCRINOLOGY AND METABOLISM
- G1 arrest and expression of cyclin-dependent kinase inhibitors in tamoxifen-treated MCF-7 human breast cancer cells
- (2008) Akira ICHIKAWA et al. Human Cell
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started